GTC
Ghost Tree Capital Portfolio holdings
AUM
$276M
This Quarter Return
-1.82%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$331M
AUM Growth
-$15.7M
(-4.5%)
Cap. Flow
-$15M
Cap. Flow
% of AUM
-4.53%
Top 10 Holdings %
Top 10 Hldgs %
38.48%
Holding
95
New
21
Increased
12
Reduced
19
Closed
26
Top Buys
| 1 |
SHPG
Shire pic
SHPG
|
$17M |
| 2 |
Merck
MRK
|
$13.2M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$7.92M |
| 4 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$7.61M |
| 5 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$7.09M |
Top Sells
| 1 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$12.4M |
| 2 |
Edwards Lifesciences
EW
|
$10.2M |
| 3 |
Puma Biotechnology
PBYI
|
$10.1M |
| 4 |
Sarepta Therapeutics
SRPT
|
$9.21M |
| 5 |
CYNO
Cynosure, Inc. Class A
CYNO
|
$7.64M |
Sector Composition
| 1 | Healthcare | 91.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Agios Pharmaceuticals
AGIO
$2.36B
| $5.84M | 1.41% |
+140,000
| New | +$5.84M |
|
27
Perrigo
PRGO
$3.21B
| $5.83M | 1.4% |
+70,000
| New | +$5.83M |
|
|
EPZM
28
DELISTED
Epizyme, Inc
EPZM
| $5.75M | 1.38% |
+475,000
| New | +$5.75M |
|
|
NSTG
29
DELISTED
NanoString Technologies, Inc.
NSTG
| $5.58M | 1.34% |
250,000
-125,000
| -33% | -$2.79M |
|
30
Invesco CurrencyShares Swiss Franc Trust
FXF
$375M
| $4.35M | 1.05% |
+46,400
| New | +$4.35M |
|
31
Biogen
BIIB
$20.5B
| $4.25M | 1.02% |
15,000
| – | – |
|
|
ENDP
32
DELISTED
Endo International plc
ENDP
| $4.12M | 0.99% |
+250,000
| New | +$4.12M |
|
|
FOMX
33
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $4.05M | 0.98% |
365,000
+207,038
| +131% | +$2.3M |
|
|
WMGI
34
DELISTED
Wright Medical Group Inc
WMGI
| $4.02M | 0.97% |
175,000
-250,000
| -59% | -$5.75M |
|
|
ONCE
35
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $3.99M | 0.96% |
+80,000
| New | +$3.99M |
|
|
ENTL
36
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
| $3.79M | 0.91% |
200,000
| – | – |
|
|
QGENF
37
DELISTED
QIAGEN NV
QGENF
| $3.78M | 0.91% |
135,000
-65,000
| -33% | -$1.82M |
|
38
Neurogene
NGNE
$284M
| $3.72M | 0.89% |
11,250
-1,250
| -10% | -$413K |
|
39
iRhythm Technologies
IRTC
$5.67B
| $3.46M | 0.83% |
+115,182
| New | +$3.46M |
|
40
Aclaris Therapeutics
ACRS
$223M
| $3.26M | 0.78% |
120,000
-55,000
| -31% | -$1.49M |
|
41
Acadia Pharmaceuticals
ACAD
$4.34B
| $2.88M | 0.69% |
100,000
-100,000
| -50% | -$2.88M |
|
42
IRIDEX
IRIX
$23.5M
| $2.81M | 0.68% |
+200,000
| New | +$2.81M |
|
|
ZGNX
43
DELISTED
Zogenix, Inc.
ZGNX
| $2.73M | 0.66% |
225,000
-100,000
| -31% | -$1.22M |
|
|
MDCO
44
DELISTED
Medicines Co
MDCO
| $2.55M | 0.61% |
+75,000
| New | +$2.55M |
|
45
Xenon Pharmaceuticals
XENE
$2.99B
| $2.5M | 0.6% |
325,000
| – | – |
|
|
TSRO
46
DELISTED
TESARO, Inc.
TSRO
| $2.29M | 0.55% |
17,000
| – | – |
|
|
BLUE
47
DELISTED
bluebird bio
BLUE
| $1.85M | 0.45% |
2,316
-2,316
| -50% | -$1.85M |
|
48
Rigel Pharmaceuticals
RIGL
$710M
| $1.67M | 0.4% |
70,000
| – | – |
|
49
Veracyte
VCYT
$2.41B
| $1.55M | 0.37% |
200,000
-164,000
| -45% | -$1.27M |
|
50
Incyte
INCY
$17B
| $1.3M | 0.31% |
+13,000
| New | +$1.3M |
|